Label-free measurement of microbicidal gel thickness using low-coherence interferometry

Area of Science:

• Biomedical Optics
• Drug Delivery Systems
• Nanotechnology

Background:

• Microbicides are crucial for preventing sexually transmitted infections like HIV.
• Accurate measurement of topical formulation thickness is vital for drug delivery efficacy.
• Existing methods for measuring gel thickness are often invasive or require exogenous agents.

Discussion:

• Spectral-domain low-coherence interferometry (LCI) provides a non-invasive approach to measure microbicide gel thickness.
• The LCI device analyzes interference patterns without requiring fluorescent labeling.
• This method offers a clinically relevant alternative to existing fluorescence-based techniques.

Key Insights:

• LCI accurately measures microbicide gel thickness on a calibration test socket.
• The LCI method eliminates the need for exogenous agents like fluorescein.
• Validation confirms LCI's effectiveness compared to fluorescence-based measurements.

Outlook:

• The LCI-based device has the potential to significantly impact in vivo measurements of topical formulations.
• This technology can optimize the development and application of microbicides.
• Further research can explore LCI's application in other biomedical contexts requiring precise thickness measurements.